These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23244171)

  • 41. Complex Evaluation of Surfactant Protein A and D as Biomarkers for the Severity of COPD.
    Lv MY; Qiang LX; Wang BC; Zhang YP; Li ZH; Li XS; Jin LL; Jin SD
    Int J Chron Obstruct Pulmon Dis; 2022; 17():1537-1552. PubMed ID: 35811742
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Correlation analysis of surfactant protein A and surfactant protein D with lung function in exhaled breath condensate from lung cancer patients with and without COPD.
    Lin X; Wu Z; Fan Y; Chi M; Wang X; Zhang X; Sun D
    Mol Med Rep; 2017 Oct; 16(4):4948-4954. PubMed ID: 28791362
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasma surfactant Protein-D levels in healthy subjects and COPD patients.
    Khan RA; Waseem HM; Ahmad HU; Lone KP
    J Pak Med Assoc; 2019 Apr; 69(4):494-498. PubMed ID: 31000851
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of Surfactant-Associated Protein D Gene Polymorphisms with the Risk of COPD: a Meta-Analysis.
    Liao Y; Huang C; Wang J; Fan X
    Clinics (Sao Paulo); 2019; 74():e855. PubMed ID: 31116231
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biomarker Development for Chronic Obstructive Pulmonary Disease. From Discovery to Clinical Implementation.
    Sin DD; Hollander Z; DeMarco ML; McManus BM; Ng RT
    Am J Respir Crit Care Med; 2015 Nov; 192(10):1162-70. PubMed ID: 26176936
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multidrug resistance-associated protein-1 (MRP1) genetic variants, MRP1 protein levels and severity of COPD.
    Budulac SE; Postma DS; Hiemstra PS; Kunz LI; Siedlinski M; Smit HA; Vonk JM; Rutgers B; Timens W; Boezen HM;
    Respir Res; 2010 May; 11(1):60. PubMed ID: 20487524
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Surfactant protein gene A, B, and D marker alleles in chronic obstructive pulmonary disease of a Mexican population.
    Guo X; Lin HM; Lin Z; Montaño M; Sansores R; Wang G; DiAngelo S; Pardo A; Selman M; Floros J
    Eur Respir J; 2001 Sep; 18(3):482-90. PubMed ID: 11589345
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic utility of admission cell-free DNA levels in patients with chronic obstructive pulmonary disease exacerbations.
    Avriel A; Rozenberg D; Raviv Y; Heimer D; Bar-Shai A; Gavish R; Sheynin J; Douvdevani A
    Int J Chron Obstruct Pulmon Dis; 2016; 11():3153-3161. PubMed ID: 28003743
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Associating serum biomarkers with genetic susceptibility to chronic obstructive pulmonary disease: a step towards improved diagnosis and therapy?
    Hizawa N
    Am J Respir Crit Care Med; 2012 Dec; 186(12):1201-2. PubMed ID: 23250494
    [No Abstract]   [Full Text] [Related]  

  • 50. Growth Differentiation Factor-15 Is a Novel Biomarker Predicting Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Mutlu LC; Altintas N; Aydin M; Tulubas F; Oran M; Kucukyalin V; Kaplan G; Gurel A
    Inflammation; 2015 Oct; 38(5):1805-13. PubMed ID: 25820390
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Different expression of circulating microRNA profile and plasma SP-D in Tibetan COPD patients.
    Shi XF; He X; Sun ZR; Wang JX; Gu YH; Xie YB; Duo J
    Sci Rep; 2022 Mar; 12(1):3388. PubMed ID: 35232961
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mannose-binding lectin protein and its association to clinical outcomes in COPD: a longitudinal study.
    Mandal J; Malla B; Steffensen R; Costa L; Egli A; Trendelenburg M; Blasi F; Kostikas K; Welte T; Torres A; Louis R; Boersma W; Milenkovic B; Aerts J; Rohde GG; Lacoma A; Rentsch K; Roth M; Tamm M; Stolz D
    Respir Res; 2015 Dec; 16():150. PubMed ID: 26684757
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnostic Utility of Biomarkers in COPD.
    Ambade VN; Sontakke AN; Barthwal MS; Tyagi R; Basannar DR
    Respir Care; 2015 Dec; 60(12):1729-42. PubMed ID: 26106205
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Involvement of surfactant protein D in emphysema revealed by genetic association study.
    Ishii T; Hagiwara K; Kamio K; Ikeda S; Arai T; Mieno MN; Kumasaka T; Muramatsu M; Sawabe M; Gemma A; Kida K
    Eur J Hum Genet; 2012 Feb; 20(2):230-5. PubMed ID: 21934714
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Four SNPs and Systemic Level of FOXP3 in Smokers and Patients with Chronic Obstructive Pulmonary Disease.
    Chu S; Zhong X; Zhang J; Lai X; Xie J; Li Y
    COPD; 2016 Dec; 13(6):760-766. PubMed ID: 27310557
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Systemic inflammatory biomarkers and co-morbidities of chronic obstructive pulmonary disease.
    MacNee W
    Ann Med; 2013 May; 45(3):291-300. PubMed ID: 23110517
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic polymorphism and chronic obstructive pulmonary disease.
    Yuan C; Chang D; Lu G; Deng X
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1385-1393. PubMed ID: 28546746
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Is serum iron responsive protein-2 level associated with pulmonary functions and frequent exacerbator phenotype in COPD?
    Acet Öztürk NA; Görek Dilektaşlı A; Demirdöğen E; Coşkun F; Ursavaş A; Karadağ M; Kunt Uzaslan E
    Tuberk Toraks; 2020 Sep; 68(3):252-259. PubMed ID: 33295723
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Systemic soluble receptor for advanced glycation endproducts is a biomarker of emphysema and associated with AGER genetic variants in patients with chronic obstructive pulmonary disease.
    Cheng DT; Kim DK; Cockayne DA; Belousov A; Bitter H; Cho MH; Duvoix A; Edwards LD; Lomas DA; Miller BE; Reynaert N; Tal-Singer R; Wouters EF; Agustí A; Fabbri LM; Rames A; Visvanathan S; Rennard SI; Jones P; Parmar H; MacNee W; Wolff G; Silverman EK; Mayer RJ; Pillai SG;
    Am J Respir Crit Care Med; 2013 Oct; 188(8):948-57. PubMed ID: 23947473
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Plasma Surfactant Protein-A Levels In Healthy Subjects And Chronic Obstructive Pulmonary Disease Patients.
    Waseem HM; Khan RA; Lone KP
    J Ayub Med Coll Abbottabad; 2020; 32(1):3-8. PubMed ID: 32468745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.